Xeloda (Capecitabine) is an oral chemotherapy medication primarily used to treat various types of cancer, including breast cancer, colorectal cancer, and gastric cancer. It is a prodrug that is converted into 5-fluorouracil (5-FU) in the body, which interferes with the DNA of cancer cells, inhibiting their growth and division.

Uses:

• Breast cancer: Often used in combination with other therapies for metastatic or early-stage disease.
• Colorectal cancer: For advanced stages, often in combination with other treatments like oxaliplatin.
• Gastric cancer: For metastatic or advanced disease.

How it works:

Capecitabine is metabolized in the body into 5-fluorouracil (5-FU), which interferes with DNA synthesis in cancer cells, slowing or stopping their growth.

Common Side Effects:

• Nausea and vomiting
• Diarrhea
• Hand-foot syndrome (redness, swelling, or pain on the palms of hands or soles of feet)
• Fatigue
• Loss of appetite

Serious Side Effects:

• Severe skin reactions
• Liver issues
• Blood disorders (e.g., low white blood cell count)

Precautions:

• Ought to be utilized circumspectly in patients with liver or kidney issues.
• Regular blood tests may be needed to monitor blood cell counts and liver function.

Xeloda is often part of a broader treatment regimen and is considered a critical component in managing several types of advanced cancers. Always follow your healthcare provider's instructions regarding dosage and monitoring during treatment.